May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Neovascular Ingrowth Site Photothrombosis of "Classic" or "Predominantly Classic" Subfoveal Choroidal Neovascularization Caused by Age-Related Macular Degeneration
Author Affiliations & Notes
  • R.A. Costa
    Ophthalmology, Federal University of Sao Paulo, Araraquara, Brazil
  • D. Calucci
    Ophthalmology, Federal University of Sao Paulo, Araraquara, Brazil
  • L.A. Melo Jr
    Ophthalmology, Federal University of Sao Paulo, Araraquara, Brazil
  • J.A. Cardillo
    Ophthalmology, Federal University of Sao Paulo, Araraquara, Brazil
  • M.E. Farah
    Ophthalmology, Federal University of Sao Paulo, Araraquara, Brazil
  • Footnotes
    Commercial Relationships  R.A. Costa, Akorn, Inc. C; D. Calucci, None; L.A. Melo Jr, None; J.A. Cardillo, Akorn, Inc. C; M.E. Farah, Akorn, Inc. C.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1792. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      R.A. Costa, D. Calucci, L.A. Melo Jr, J.A. Cardillo, M.E. Farah; Neovascular Ingrowth Site Photothrombosis of "Classic" or "Predominantly Classic" Subfoveal Choroidal Neovascularization Caused by Age-Related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1792.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the visual, angiographic, and anatomical outcomes after neovascular ingrowth site photothrombosis for the management of "classic" or "predominantly classic" subfoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). Methods: Interventional noncomparative case series. After neovascular ingrowth site identification, twelve consecutive AMD patients were submitted to focal treatment of such sites by the use of continuous 810 nm laser and intravenous indocyanine green (ICG) infusion. Prospective evaluation with fluorescein and ICG angiography as well as optical coherence tomography (OCT) was performed at regular intervals up to 12 months following treatment. Results: With treatment, visual acuity improved 3 or more ETDRS lines in 8 (66.6%), improved 1 or 2 lines in 3 (25%) and remained stable in 1 (8.3%). The mean change in vision from baseline after the procedure was statistically significant (p < 0.00001, repeated measures ANOVA), with an improvement of 1.51 and 2.6 lines over baseline observed, respectively, at 1 and 48 weeks (p = 0.00003 and p = 0.00001, Dunnett’s test). Non perfusion of the entire neovascular complex was achieved in all patients within the first week following treatment. Sluggishness of CNV blood flow was seen 48 weeks after treatment, and OCT disclosed considerable resolution of the exudative manifestations with all patients presenting foveal heights below 180 microns. Complications included transient occlusion of retinal capillaries in three patients over the site of laser application. Conclusions: The use of 810 nm continuous light after intravenous ICG dye bolus induced selective CNV hipoperfusion in all treated eyes. This finding was either consistent with the visual acuity improvement or maintenance observed in these patients as well as with the considerable restoration of the retinal architecture seen in OCT evaluation 12 months after neovascular ingrowth site photothrombosis.  

Keywords: age-related macular degeneration • choroid: neovascularization • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×